Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Triple Negative Breast Neoplasms
×
Trastuzumab
×
Clear all
Filters
3
NCT03907800
2022-10-27
NeoPATH
Ruijin Hospital
Phase 2
Unknown
100 enrolled